Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-25-001026
Filing Date
2025-04-08
Accepted
2025-04-08 20:00:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10564
2 ex991to13g10022apvo_040825.htm EX-99.1 5221
  Complete submission text file 0000921895-25-001026.txt   17420
Mailing Address 159 JENNINGS RD COLD SPRING HARBOR NY 11724
Business Address 159 JENNINGS RD COLD SPRING HARBOR NY 11724 631-987-0235
BIGGER CAPITAL FUND L P (Filed by) CIK: 0001288478 (see all company filings)

EIN.: 900131165 | State of Incorp.: DE
Type: SCHEDULE 13G

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Subject) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89584 | Film No.: 25823312
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)